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The treatment of valvular heart disease represents approximately 20% of all cardiac 
surgery. One alternative of this treatment is replacement of diseased valve with bioprosthetic 
heart valves (BHV). These BHV are manufactured from divergent human or animal tissues 
e.g. porcine pericardium. 
Although this treatment is beneficial for certain groups of patients, it is susceptible to 
some complications such as rejection of the xenograft or early BHV deterioration. In both of 
them the immune system is involved and both might result in BHV failure. 
This study aims to isolate and characterize important targets of this immune response – 
glycosphingolipids (GSL). Therefore, 8 non-acidic and 7 acidic GSL from porcine 
pericardium have been isolated and characterized by mass spectrometry and carbohydrate 
binding assays.  
The acidic GSL from goat erythrocytes have been isolated and characterized. Notable is 
characterization of a new NeuGc-containing GSL - NeuGc-GT1b ganglioside. 
And finally, 60 binding assays examined the presence of antibodies against various GSLs 
in patient serum collected before, one and six months after BHV treatment surgery. The 
radioactive iodine-125-labeled anti-human antibodies and autoradiographic visualisation 
have been used for detection. Results were mostly negative. However, in few samples an 
increased reactivity Galα3 and NeuGc antigens was found. 
This knowledge might contribute to explanations of immune response against 
xenografts. This might help with further research on strategies preventing early BHV 
deterioration and, therefore, increase final outcome of BHV treatment of valvular heart 
disease.  
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Léčba vad srdečních chlopní představuje přibližně 20% všech kardiochirurgických 
operací. Jednou z možností léčby je náhrada vadné chlopně pomocí bioprotetické srdeční 
chlopně (BSCh). Tyto BSCh jsou zhotovovány z různých lidských nebo zvířecích tkání, např. 
ze srdečního perikardu. 
Ačkoli tato léčba je prospěšná pro určité skupiny pacientů, pojí se k ní komplikace jako 
odhojení xenotransplantátu, či časné opotřebení BSCh. V obou případech je zapojena reakce 
imunitního systému a oba mohou vyústit ve ztrátu funkce BSCh. 
Tato práce si klade za cíl izolovat a charakterizovat významné cíle imunitní odpovědi – 
glykosfingolipidy (GSL). Proto bylo z prasečího perikardu izolováno 8 nekyselých a 7 
kyselých GSL, které byly charakterizovány pomocí hmotnostní spektrometrie a carbohydrate 
binding assay. 
Z kozích erytrocytů byly izolovány a charakterizovány kyselé GSL. Za zmínku stojí 
charakterizace nového GSL obsahujícího NeuGc - NeuGc-GT1b gangliosidu. 
Nakonec byla pomocí 60 binding assayí zkoumána přítomnost protilátek, proti různým 
GSL, v séru pacientů, odebraném před, jeden a šest měsíců po léčbě pomocí BSCh. Pro 
dektekci byly užity protilátky proti lidským protilátkám značené pomocí radioaktivního 
jódu-125 a autoradiografická vizualizace. Výsledky byly převážně negativní. V několika 
případech však byla nalezena zvýšená reaktivita vůči Galα3 a NeuGc antigenům. 
Tyto poznatky mohou přispět k vysvětlení imunitní odpovědi na xenotransplantáty, což 
dále může pomoci v dalším výzkumu strategií předcházení časnému opotřebení BSCh a tedy 
i zvýšit celkovou úspěšnost léčby nemocí chlopenních vad pomocí BSCh. 
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AHXR Acute humoral xenograft rejection 
ADCC Antibody dependent cellular cytotoxicity 
BHV Bioprosthetic heart valve 
BSCh Bioprotetická srdeční chlopeň 
C:M (x:x) Chloroform: methanol in ratio x:x 
C:M:W Chloroform: methanol: distilled water 
CBA Carbohydrate binding assay 
CMAH Cytidine monophosphate-N-acetylneuraminic acid hydroxylase 
DEAE Diethylaminoethyl cellulose 
DiChl Dichlormethane 
ESI Electrospray ionization 
Fuc Fucose 
Gal Galactose 










HAR Hyperacute rejection 
Hex Hexose 
HexNAc N-Acetylhexoseamine 
-KO Knocked out gene for - 
LC-ESI/MS Liquid chromatography-electrospray ionization/MS 
Man Mannose 
MeOH Methanol 
MHV Mechanical heart valve 
MiC Methanol in chloroform 
MS Mass spectrometry 
NeuAc N-Acetylneuraminic acid 
NeuGc N-Glycolylneuraminic acid 
NGal-Ab Antibodies targeted against non-Galα3 antigens 
PBS Phosphate buffered saline 
SAC Silicic acid chromatography 




 This thesis is a part of the Translink project, which concerns about assessing the mid- to 
long-term risk factors and aims to improve outcome of xenotransplantation of animal heart 
valves to the patients. This kind of treatment using bioprosthetic heart valves is one of the 
available alternatives for transplantation of human heart valves. 
 Bioprosthetic heart valves (BHV) are routinely used in the clinical practice to replace 
diseased heart valves. However, even BHVs suffer from late dysfunction, i.e. the valves also 
deteriorate with time. The xenografts will expose molecules on their surfaces which may 
provoke immune system of the recipient, which might lead to subsequent graft damage. In 
humans, there are a number of preformed antibodies directed against carbohydrate antigens. 
Thus, in addition to the well-known blood group ABO system, humans have performed 
antibodies directed towards carbohydrates found exclusively in animals e.g. the Galα3 
epitope and N-glycolylneuraminic acid (NeuGc). Here we aim to identify glycosphingolipids 
on animal tissues used for bioprosthetic heart valves, and evaluate the immune reactions 
towards these potential antigens in patients after transplantation of bioprosthetic heart 
valves. 
1.1. Carbohydrates at the cell surface 
In nature, all kind of cells are covered by surface membrane comprising, except ordinary 
lipids, also different types of glycoconjugates. From this reason, the surface of every cell is 
densely covered with layer of sugars, so-called glycocalyx. 
Glycoconjugates are macromolecules which consist of one or more monosaccharide or 
oligosaccharide units (the glycone) linked by covalent bond to non-carbohydrate compound 
(the aglycone). All kind of cells in nature are covered by different types of glycoconjugates 
(Varki, et al., 2009) 
 Such a large diversity of glycoconjugates on the cell surface caused by plurality of 
monosaccharides units and their derivates, structural linking of saccharides, and also 
different kinds of core chains plays important role in communication. (Varki, et al., 2009) 
Figure 1: Part of membrane with glycocalyx, adapted from: (Anonymous, 2011) 




In general view, glycoconjugates (or glycans) are extremely various group of chemical 
compounds. The glycone part of the macromolecule contains the main part of the mass in 
naturally occurring glycoconjugates. 
Glycoconjugates are classified depending on whether the aglycone is protein or lipid and 
according to the way of binding (O-glycosylation, N- glycosylation, …).  
Glycoproteins are mainly the N-linked, where the oligosaccharide chain is bound to the 
nitrogen atom of amidic group of the side chain of asparagine, or O-linked where the side 
chain of serine or threonine is used for linking saccharide to its free hydroxyl group. (Varki, 
et al., 2009) 
All N-linked glycans share a core sugar sequence Manα1-6(Manα1-3)Manβ1-
4GlcNAcβ1-4GlcNAcβ1-Asn-X-Ser/Thr or shorter: Man3GlcNAc2Asn. Those can be 
subclassified into three groups according to branching and composition of single branches; 
oligomannoses, complex and hybrid. (Stanley, et al., 2009) 
Figure 2: Schematic view of O- and N- linked glycoproteins, modified from (Jabbar, 2014) 
O-linked glycans in eukaryotes are linked to the hydroxyl group of serine or threonine 
with carbohydrate residue of N-acetylgalactosamine (GalNAc). The largest group of O-
GalNAc glycans is called mucins for their ubiquitous presence in mucous secretions on cell 
surface and in body fluids. (Brockhausen, et al., 2009) 
The simplest mucin glycan, which is N-acetylgalactosamine linked to Ser/Thr is called 
also Tn glycan. The extension by galactose (Gal), sulfate, fucose (Fuc), sialic acids or next 
GalNAc forms 4 basic core chains, which can be further modified by i.e. acetylation or 
sulfation. By this, there is reached such a great variability giving to O-glycans possibility to 
act like receptors and antigens in many processes in body like i.e. T-lymphocyte activation 
or sperm-egg interaction. (Brockhausen, et al., 2009) 
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Proteoglycans are heavily glycosylated macromolecules, where the carbohydrate 
component represents more than 95% of the molecule mass. Usually there are repeating 
polysaccharides sequences attached by xylosyl-serine linkage the one central protein. They 
occur in the extracellular matrix produced by cells of connective tissues, but they can also be 
attached directly to the cytoplasmic membrane. (Varki, et al., 2009)  
Whereas the two previous categories can appear both in the cell membrane and outside 
the cell, glycolipids are anchored by their nonpolar lipid part only in the cell membrane.   
Glycolipids can be either glycerolipids or sphingolipids. In both cases there is only one 
carbohydrate chain to each lipid (Barone, 2014b) 
 
Figure 3: Schematic formulas of glycolipids, adapted from (RicHard-59, 2012) 
1.3. Glycosphingolipids 
Since the discovery of glycosphingolipids it has been shown that they are important 
component for many essential functions like: cell adhesion, cell growth, cell regulation, 
differentiation, intercellular interaction, cell recognition, interaction with signal molecules, 
microbes and microbial toxins. (Watts, 2003) 
 The glycosphingolipid (GSLs) comprises of two moieties: 
The first is the oligosaccharide chain containing from one to approximately forty 
monosaccharide units. The variability of its structure is due to variations in types of 
carbohydrate units, in binding positions, branching, different sequence order and anomeric 
configuration. More than 350 different carbohydrate chains on glycosphingolipids have been 
discovered. (Merril, 2011) 
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The second part is nonpolar and incorporated into the outer leaflet of the cell membrane. 
It consists of a long chain aliphatic amino-alcohol (sphingoid base) acylated on the nitrogen 
by a fatty acid. (Watts, 2003) 
The most common amino-alcohols are sphingosine, sphinganine and 
phytosphingosine. The fatty acids are mainly in the range from 16 to 24 carbon atoms, and 
are either hydroxylated or not.  Compound where a fatty acid and sphingosine (after 
Egyptian Sphinx, because of the similarity between its difficult enigmas and problematic 
description of sphingosine structure) are bound together was named ceramide. (Varki, et al., 
2009) 
The word ceramide comes from Latin cera (wax) and -amid referring to amidic group. 
(Wikipedia contributors, 2016).  Ceramide structures vary in length, rate of hydroxylation 
and number of unsaturated bonds of both chains, which leads to great diversity and might 
influence presentation of glycans on the cell membrane. 
β-linked galactose (GalCer) or glucose (GlcCer)  is usually bound to ceramide. In higher 
animals, mainly GlcCer extended with larger carbohydrate chains occur. GalCer is rarely 
extended. Typical substitution of GlcCer is with a β-linked galactose on the C-4 hydroxyl of 
glucose – this altogether is called lactosylceramide (Galβ1-4GlcβCer). Further extensions of 
it then forms a series of core structures which are the base of the GSL nomenclature. 
Figure 4: Glycosphingolipidic subfamily series and nomenclature, adapted from  
(Schnaar, et al., 2009) 
In the official nomenclature GSLs can be described in more ways. The first option is 
describing the whole structure by abbreviations for sugars, numbers and Greek letters 
referring to type of binding to another structure. The second is naming GSL using the 
abbreviation expressing subfamily series and variant i.e. Lc4Cer. To this core structure name 
are then added next substituents. (Schnaar, et al., 2009) 
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The third is used especially for gangliosides in daily use. Common GSLs are named 
simply like “GM3”, where first letter refers subfamily (G = gangliosides), the second letter 
refers to the number of sialic residues (M = mono) and the number which denotes position 
on thin-layer chromatography plate, (GM1 is more polar than GM2 or GM3 and occurs 
closer to the start). (Schnaar, et al., 2009) 
 
Figure 5: Structure of GM1, GM2 and GM3, adapted from: (Voet, et al., 2008) 
 Non-acidic glycosphingolipids 
Non-acidic (or neutral) glycosphingolipids do not contain charged carbohydrates, 
neither other ionic groups. The most common in human peripheral tissues are core chains 
from globo, lacto and neolacto families. The determinants of ABO or Lewis blood group 
systems are often found on neutral GSL core chains. (Varki, et al., 2009) 
 Acidic glycosphingolipids 
Acidic glycosphingolipids have carbohydrates with sulfate groups or sialic acid. The 
latter are known as gangliosides, because of its discovery in the “ganglion” or cluster in the 
brain of patients with from Tay-Sachs disease. (Schnaar, et al., 2009) 
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Gangliosides (GSLs substituted by sialic acid) have mainly ganglio or neolacto core 
chains, but lacto and globo core are also possible. The major forms of sialic acid in 
mammalian GSLs are N-glycolylneuraminic acid (NeuGc) and N-acetylneuraminic acid 
(NeuAc). Those two diverge only on C-5 position, where NeuAc has acetyl group and NeuGc 
a glycolyl group. (Schauer, 1982) 
NeuAc is the precursor of NeuGc, and NeuAc is the only form of sialic acid occurring in 
humans due to a mutation in the human CMP-Neu5Ac hydroxylase (CMAH) gene that 
occurred over 2 million years ago. (Varki, 2001) 
The most common sulfated GSL is sulfatide (SO3-3GalCer) but a few GSLs based on 
lacto- ganglio and globo core chains have also been described. (Nagai, 1989) 
Figure 6: Sialic acids, adapted from: (Barone, 2014b) 
 Metabolism of GSLs 
Biosynthesis 
Glycans are secondary gen products, i.e. their structure cannot be read directly from 
DNA. Instead the glycoconjugates are created by enzymes e.g. glycotransferases, 
sulfotransferases, and transporters encoded in the DNA. These enzymes perform 
posttranslational modifications of proteins and glycosylations of core lipids. 
Most of pathways are connected with the luminal side of endoplasmic reticulum and 
Golgi apparatus. However, some pathways are present also in the nucleus and cytoplasm. 
(Varki, et al., 2009) 
The final outcome of glycosylation is influenced by a number of factors, as e.g. 
distribution of enzymes responsible for start and continuing of glycosylation, their activity, 
accurate income of precursors and sugars derived to be activated form of nucleotide sugars 
or balance between biosynthesis and degradation. 
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The biosynthesis of galactosylceramide, galabiaosylceramide and sulfatide starts on the 
cytosolic side of endoplasmic reticulum, where the ceramides are assembled. Thereafter they 
are moved to luminal side of endoplasmic reticulum in order to add galactose by a ceramide 
galactosyltransferase. For biosynthesis of sulfated GSLs the galactosylceramide is transferred 
to the luminal Golgi apparatus, where it is modified by sulfotransferase. 
More composite glycosphingolipids are made by different process starting with ceramide 
transfer to cytosolic part of Golgi, where glucose is added by ceramide glucosyltransferase. 
After that it is moved to the luminal side of Golgi to further glycosylation by sequential work 
of enzymes attached to the membrane. At the end of biosynthesis, newly synthesized GSLs 
are relocated by vesicular transport and incorporated into the cell membrane. 
 
Biodegradation 
The degradation of GSLs starts with internalization into vesicles. Fusion with endosome 
by its GSL-enriched areas of membrane may lead to the second invagination of GSLs and to 
creation of multi-compartment particle. Due to fusion of this secondary endosome with 
prolysosomes, GSLs are exposed to the hydrolytic enzymes using sphingolipid activator 
proteins (SAPs) as co-factors. Particles from degradation are then released into the 
cytoplasm, where they are used for other biosynthesis pathways or further degraded. 
(Schnaar, et al., 2009) 
 The diversity of GSLs 
A very complex distribution pattern of GSL determinants on the cell, tissue and organ 
level even within a single individual has been demonstrated by immunohistochemistry. This 
is due to differences in expression of glycosyltransferases in different cells. (Barone, 2014b) 
Different GSLs are found in different species, and this might provoke the immune system 
and could cause complications after xenotransplantation. For example isoglobo-series GSLs, 
N-glycolylneuraminic acid and GSLs with terminal Galα3 (described below) (are not present 
in human, although such GSLs are present in dog, horse, rat or pig. (Breimer, 1981) 
There is also a diversity among the individuals, where different glycosphingolipids are 
expressed in different subjects, as e.g. GSLs with determinant of the ABO and Lewis blood 
group systems. (Bjork, 1987) 
Even glycosphingolipids in various organs of one individual may diverge. One example 
is the difference between epithelial cells in the small and large intestine, which mainly have 
lacto core chains and the pancreas, where globo and lacto core chains are in equal balance. 
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Diversity among the cells within an organ is demonstrated by human blood, where the 
main GSLs of erythrocytes are based on the globo core, while the major GSLs in human 
neutrophils have neolacto core chains and GSLs with globo core chains are completely 
absent. (Bjork, 1987) 
1.4. Xenotransplantation 
“Transplantation of cells, tissues and organs between individuals of different species, 
commonly known as xenotransplantation, has been studied with the aim to solve the critical 
shortage of human graft sources for clinical transplantation.” (Vadori, et al., 2015, p.239) 
 The recipients’ humoral immune response is the dominating cause of graft damage and 
eventually loss of the transplanted organs, tissues or cells. Moreover, the histopathological 
features and the kinetics of the appearance of specific antibodies is very similar to the 
situation occurring after allotransplantation. Thus, it is expected that strategies aimed at 
avoiding graft damage may be applied to xenotransplantation as well as to 
allotransplantation in order to extend long-term graft survival. (Vadori et Cozzi, 2015) 
 Although our knowledge is still incomplete, there are several extracellular materials 
which are already in use in cardiac, oesophageal, urinary tract and in orthopaedic surgery to 
restore functions of human organs. In addition, transplantation of whole bioartificial organs, 
made from xenogeneic scaffolds and repopulated by suitable cells, and using organs, such as 
heart, liver or kidneys from genetically modified animals, seems to be a promising approach 
which still needs to be further explored.  
 The immunological barriers in transplantation 
An increasing number of xenotransplantation procedures are performed in wide-spread 
clinical practice, therefore the increasing evidence of contribution by both parts of immunity, 
innate and adaptive, is now being revealed. (Vadori et Cozzi, 2015) 
  Cell mediated reactions 
Neutrophils are the most common circulating leukocytes and are also the first cell 
population responding after transplantation of xenografts (Ezzelarab, et al., 2009). In 
particular, their activity (chemotaxis and transmigration) rapidly increased after exposition 
to porcine endothelial cells, compared to the human endothelium after allotranslplantation. 
This means that neutrophils distinguish between allogeneic and xenogeneic surfaces. In 
addition, penetration of neutrophils into the target tissue is enhanced by pro-inflammatory 
cytokines. (Vadori et Cozzi, 2015) 
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Production of reactive oxygen metabolites (ROMs), IL-1a/b, IL-6 and IL-8 by neutrophils 
and increased expression of P-selectin and VCAM-1 on the endothelium facilitate 
infiltration of NK cells. NK cells have direct cytotoxic activity on target cell which lack self-
MHC class I molecules and do not provide to NK cell inhibitory signals. It has been reported 
that NK cells quickly migrate into porcine xenografts perfused ex vivo with human blood. 
(Vadori et Cozzi, 2015) 
Since the Galα3 residues (see below) are probably not included in the increased cytotoxic 
potential of NK cell on the porcine graft, it has been suggested that NK cells react to unknown 
glycosylation patterns and that NK cells take part in the antibody-mediated rejection reaction 
by antibody dependent cellular cytotoxicity (ADCC). (Resch, et al., 2015) 
Monocytes and activated macrophages have major role in the cellular part of the 
immune response against vascularized and either nonvascularized grafts.  Macrophages are 
also regulated by a high number of cytokines. However, in any case, their reactions have to 
be confirmed by CD4+ T-cells. (TH lymphocyte). In particular, the phagocytic activity is 
modulated by ADCC mechanisms or by direct cell-to-cell contact. (Vadori et Cozzi, 2015) 
Activated macrophages infiltrate graft tissue very early and persist there until graft 
rejection. Thus, they are considered as possible contributors to the transplanted graft 
miscarriage due to rejection. (Ezzelarab, et al., 2009). Immunity response mediated by 
macrophages has been revealed to occur more often after xenotransplantation in comparison 
with allotransplantation. (Griesemer, et al., 2014)  
The role of Galα3 in increasing monocyte adhesion remains unclear, since macrophage 
infiltration has been found also in GalT-KO (α-1,3-galactosyltransferase gene knocked out) 
donor porcine islet grafts. (Thompson, et al., 2011) 
INF-γ produced by NK cells and other cytokines stimulate T-cell activity. (Griesemer, et 
al., 2014). Experimental evidence suggested that T-cells are the next part of the complex 
reactions against transplanted xenogeneic graft. T-cells infiltrate the graft, where they are 
probably in cooperation with macrophages part of immune response leading to rejection of 
the graft. (Vadori et Cozzi, 2015) 
These cells play major part in the rejection process of non-vascularized xenografts. 
Notable is also that T-cells are the main cause of anti-pig cell cytotoxicity. It has also been 
shown that Galα3 residues attached to the porcine epithelium stimulates T-cell response by 
an unexplained mechanism. (Vadori et Cozzi, 2015) 
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 Antibody mediated reaction 
Adaptive immunity response, in particular mediated by antibodies, has the most 
important role in xenograft rejection of solid organs, tissues and even cells. Antibodies are 
produced by B-cells and their mature form plasma cells in a process that is thought to be 
mainly T-cell dependent. 
Studies of the binding specificities of the antibodies have been done on both human and 
primates. The majority of them were focused on the well-known xenogeneic antigen epitope 
Galα3Galβ4GlcNAc-R (Galα3) which is the main target in antibody mediated response of 
humans against xenograft. This glycodeterminant is present in all animals except Old World 
monkeys and humans. In addition, around 1% of circulating B-cells in human serum are 
producing anti-Galα3 antibodies. There are several approaches targeting the B-cells 
producing anti- Galα3 antibodies and the pathway between them and T-cells.  
In this context, anti-CD20 agents, anti-CD19 monoclonal antibodies and drug 
interrupting communication CD40 and CD154 like have been tested in order to suppress 
graft rejection. (Vadori et Cozzi, 2015) 
All these ways provide significant prolongation of graft survival. 
 
Generally, there are two divergent kinds of immune response which may cause rejection 
of the xenograft: 
 
a) Hyperacute rejection (HAR) 
The HAR occurs from a few minutes to hours following the transplantation. The 
rejection is caused by antibodies pre-existing in the body of the recipient. “Immunoglobulins 
and complement are deposited in the vessel wall, causing severe endothelial injury and fibrin-
platelet rich thrombi. Moreover, a rapid accumulation of neutrophils is observed within the 
capillaries.” (Vadori et Cozzi, 2015 p. 240) There is also thrombotic blockage of capillaries 
and necrosis in arterial walls. This all together may then lead to the ultimate destroying of 
the graft.  
b) Acute humoral xenograft rejection (AHXR) 
The AHXR may appear within days after transplantation due to antibodies elicited as a 
reaction against the xenograft. This reaction is similar to rejection after allotransplantation 
from an inappropriate donor. “The histological features of AHXR of a solid organ xenograft 
are IgM, IgG, C4d and C5b-9 deposition, loss of capillary integrity, endothelial cell death and 
extensive fibrin deposition.” (Vadori et Cozzi, 2015, p.241) 
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Whereas HAR is performed mainly by naturally present IgM antibodies, the AHXR is 
mediated by elicited IgM and IgG antibodies. The humoral response is also performed by 
other mechanisms like antibody dependent cell mediated cytotoxicity (ADCC), 
inflammation and endothelium in a state supporting coagulation and thrombosis. In 
addition, activation of the classical complement system creating the membrane attack 
complex has been referred as contributing in early graft damage. (Vadori et Cozzi, 2015) 
Pre-existing and elicited antibodies may also be involved in the reaction of the body 
consequence after transplantation of extracellular matrices like cartilage, pig ligaments or 
bioprosthetic heart valves. Here the participation of macrophages, activated by IgM and IgG, 
and neutrophils, seems to be pivotal in the damaging of bioprosthetic heart valves. (Vadori 
et Cozzi, 2015)  
 Carbohydrate targets of the human humoral immune response 
Epitopes of proteins and carbohydrates act like antigens in the process of humoral 
immune response. Because of their presence on the cell surface and their already noted 
structural diversity, especially among species, they represent principal barrier for successful 
xenotransplantation. 
According to some studies, pigs are considered as the most suitable source of xenografts. 
However, equine and bovine heart valve cusps are also used for BHV. (Vadori et Cozzi, 2015)  
 
a) Galα3- residue   
In previous studies it has been shown that the Galα3 residue (Galα(1,3)Galβ4GlcNAc-R 
epitope) is a major target of humoral immune response of the body.  It is composed of 
Galα(1,3)Gal dimer bound to N-acetyllactosamine and synthesized by enzyme called α-1,3-
galactosyltransferase (GalT), which is not expressed in humans and Old World monkeys and 
apes. The Galα3 is expressed in both cellular material such as porcine endothelium or 
epithelium and in extracellular matrices. (Breimer, 2011) 
This antigen has a function for signalling and inter-cell interaction like A and B blood 
group antigens. The physiologic purpose of anti-Gal antibodies is protection of against 
pathogens and malignant cells and the removal of old or abnormal blood cells which all 
express Galα3 on their surfaces. (Manji, et al., 2012) 
Removal Galα3 leads to improvement of biocompatibility and reduction of acute 
rejection reactions due to reduced titres of both pre-existing and elicited antibodies.  
(Griesemer, et al., 2014) 
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b) Non-Galα3 carbohydrate antigens 
13% of IgM and 36% of IgG in human serum bind to so-called non-Galα3 epitopes. The 
studies concerned about xenotransplantation in primates, using as a source GalT-KO pigs, 
have proved presence of antibodies against non-Galα3 epitopes (NGal-Ab) at time of onset 
of the AHXR. This led to suggestion of their role in graft damaging via complement and 
ADCC reaction. (Vadori et Cozzi, 2015) 
Pathogenic roles of NGal-Ab has been identified by Lam (2004). Further studies reported 
HAR, caused by NGal-Ab in GalT-KO pig-to-baboon xenotransplantation. The study by Yeh 
(2010) used ELISA assay to measure antibody reactivity to glycoconjugates and concluded 
that NGal-Ab are predominantly targeted to proteins. Further studies supported the 
postulation that immunogenic polypeptides are the main targets of NGal-Ab. (Byrne, et al., 
2015) 
 The exceptions to this are carbohydrate epitopes with terminal N-acetylgalactosamine 
linked to a sialic acid called N-glycolylneuraminic acids. (Byrne, et al., 2015) 
In human serum there are also naturally occurring antibodies against N-
glycolylneuraminic acid. Notably, humans do not have the enzyme for synthesis of NeuGc 
from NeuAc so called CMAH = cytidine monophosphate-N-acetylneuraminic acid 
hydroxylase. NeuGc found in human tissues is derived from milk and meat in the diet. 
(Vadori et Cozzi, 2015) 
1.5. Heart valves 
The treatment of valvular heart disease represents approximately 20% of all cardiac 
surgery worldwide and more than 250 000 heart valves are replaced every year. There are two 
basic options of valvular heart surgery – repairing and replacing them. Replacement of 
diseased valve could be done either with bioprosthetic heart valve or with mechanical valve 
prosthesis. Unfortunately, both ways are facing certain obstacles, divided according to the 
type of used prosthetic valve; and a decision, which valve type is more suitable for which 
patient, depends on number of factors. (Manji, et al., 2014) 
 Mechanical heart valves 
MHVs are fabricated of synthetic material such as polymers, metal or carbon. (Manji, et 
al., 2014)  
The greatest advantage of mechanical valve prosthesis is that MHV provides a long-term 
durability, which helps to avoid repetition of cardiac surgery associated with a higher rate of 
complications and 2-3 times higher risk of death in comparison with the initial operation. 
(Manji, et al., 2012) 
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Despite this huge benefit, they are not ideal for everybody, because implantation of MHV 
requires lifelong regulated anticoagulant treatment with associated risks. In particular, there 
are risks of spontaneous bleeding, thrombosis and thromboembolism which all might be 
fatal. The cumulative annual risk of those complications is 2 % per year. (Thus, a patient 
undergoing valve replacement in his 25 years has more than 99% percent chance of 
complication connected with anticoagulant treatment by the age of 75 years).  (Manji, et al., 
2014) 
Due to previous information and the fact that young patients are more likely to 
experience these complication because of their lower adherence to restrictions in their diet, 
their more active lifestyle (work, sport) increases risk of injury and lower drug compliance 
in general. The risk is also increased in young women who are menstruating and during the 
pregnancy due to bleeding and potential birth defects in the child. (Manji, et al., 2014) 
 Bioprosthetic heart valves 
Bioprosthetic heart valves avoid all these complications connected with lifelong 
anticoagulant treatment and due to this they are more suitable than MHVs for young people 
and people in the developing world, where it is not so easy to assure sufficient anticoagulant 
management. However, BHVs significantly deteriorate with time, which leads to necessary 
replacement connected with the risks of reoperation. This structural deterioration is age 
dependent.  
The BHV failure rate is less than 10% for patients above 65 in 10 years and for patients 
under 35 in only 5 years. Thus, those who could most benefit from BHV implantation are 
not ideal candidates. This is why in the most cases MHV are chosen as a treatment for young 
people despite anticoagulant treatment. (Manji, et al., 2012) 
 BHV material 
BHVs are made of biologic tissues of various origins. Those derived from human tissues 
are called homografts and those from animal tissues are referred to heterografts or also 
xenografts. Tissues are removed from the hearth and then cleaned, sized and fixed in 
different ways and pressures. 
Homografts are of cadaveric origin or autografts (patient’s own valve taken from one side 
(pulmonary) and transplanted to the aortic side. To the place on pulmonary side is then 
usually implanted cadaveric homograft). 
Xenografts are made from different animal tissues such as porcine aortic valve, calf 
(bovine), equine or porcine pericardium. (Singhal, et al., 2013) 
~ 22 ~ 
 
 
 BHV deterioration 
There are many causes and factors influencing the reason and the speed of the function 
loss in BHVs. The changes would be broadly divided into two groups: 
Changes related to the host 
a. The age of the host 
 Children and young adults suffer from higher risk of valve failure due to more 
competent immune system than elder adults. 
b. Host reaction to the tissue 
Except cellular reaction and damage caused by macrophages and mononuclear cells, 
the immune process mediated by humoral immunity plays important roles either in 
early reaction or in long-term valve deterioration. Side of implantation (mitral BHV 
suffers from more frequent failure due to overgrowth of the tissue), comorbid condition 
e.g. hyperparathyroidism mediates mineral metabolism and could contribute to early 
calcification) or pannus (normal tissue healing reaction after surgery, which can cause 
stenosis of valve) also plays role in the reactions to BHVs. 
 
Changes related to the device 
a. Cellular reaction – one month after transplantation almost all BHVs show mononuclear 
cell infiltrate with or without thrombus on their surface. 
b. Paravalvular leak – it causes symptoms similar to the valve failure and could be 
connected also with hemolysis or low grade jaundice. 
c. Valve thrombosis – the highest probability of valve thrombosis is during the first three 
months after surgery, and it occurs at the mitral site more often. Embolism caused by 
this is rare. 
d. Infective endocarditis – infection usually starts around the sewing ring leading to 
abscesses, tears and cusp destruction. Inflammation as a response on the presence 
common gram-negative bacilli or fungi is the main destroying force in this way. 
e. Tissue degeneration is usually slow and gradually progressive leading to cusp tears due 
to pressure changes and collagen degeneration. 
f. Calcification – This is considered to be the main cause of BHV failure.  
(Singhal, et al., 2013) (Siddiqui, et al., 2009) 




Calcic deposits are present within three years after transplantation. It is generally 
accepted that it is due to interactions between phospholipids, free aldehyde groups and other 
components of the valve with calcium ions. It can lead to stenosis and then to regurgitation 
or incompetence due to cusp tears. (Singhal, et al., 2013) 
Young people and children suffer from significantly higher rates of BHV failure caused 
by calcification due to their higher immune competence and more rapid metabolism. The 
manufacturers have already developed a several anti-calcification chemical processes (alpha-
oleic acid, Tween-80) to avoid this problem in elder people. (Manji, et al., 2014) Notably, 
some of these anti-mineralization treatments (AOA, ethanol) prevent only experimental 
cusp calcification, but not calcification in the aortic wall. (Siddiqui, et al., 2009) 
The mechanisms of valve deterioration are not fully understood, there are several studies 
that suggest a connection between inflammation, thrombogenicity, coagulation and 
calcification. 
Inflammation-calcification relationship 
It has been shown that treatment by glutaraldehyde has a protective effect against 
humoral immune reactions, but increase cellular responses. Furthermore, it has been shown 
that glutaraldehyde is not responsible for calcification and a role of a graft specific antibody 
causing calcification has been suggested. (Manji, et al., 2006) 
Moreover, animal studies have revealed that destruction of valve is significantly higher 
in xenogeneic group than in allogeneic control group and that this inflammation reaction of 
the recipient’s body could be decreased by treatment with steroids.  In addition, there was a 
linear relationship between calcification and inflammation, because the extent of 
calcification correlated with cellular infiltrate. (Manji, et al., 2006) The potential linkage may 
be through cytokine osteopontin produced by macrophages and T-Cells (Nau, et al., 1997) 
 Overcoming of obstacles 
The clinical replacement of diseased heart valve by porcine BHV underwent a big 
advancement from the first attempts in the early 1960s to the presence. The initial problem 
was to preclude a hyperacute rejection initiated by naturally occurring antibodies to the 
antigens on porcine endothelial cells. This reaction leads to complement deposition and to 
activation of the endothelium that results in interstitial haemorrhage, graft thrombosis, 
edema, ischemia and organ failure. The major target of these antibodies is galacatose-α1,3-
galactose (Galα3) present in all mammals except humans, Old World monkeys and apes. 
(Manji, et al., 2012) 
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a) Due to Galα3 antigen 
In order to prevent interaction of anti-Galα3 antibodies with the graft, various methods 
were invented such as removal of anti-Galα3 antibodies, complement inhibition, removal of 
Galα3 antigens by the enzyme α-galactosidase, and development of α-1,3-
galactosyltransferase gene-knockout (GalT-KO) pigs.. The absence of Galα3 expression 
reduces the humoral response as well as cellular immune response, and GalT-KO 
pericardium has a lower grade of calcification than wild type porcine pericardium. (Manji, 
et al., 2014) 
However, other antibody-mediated rejections (initiated by NGal-Ab), rejection caused 
by cells (NK cells, lymphocytes and macrophages) and coagulant disorders are still remaining 
barriers in xenotransplantation.  
 
b) Due to Non-Galα3 antigens 
Human serum also contains antibodies directed against N-glycolylneuraminic acid 
(NeuGc). These antibodies are possibly involved in reactions after xeno and either 
allotransplantation. (Byrne, et al., 2015) 
The presence of the NeuGc has been shown in porcine heart, pericardium and aortic and 
pulmonary valves. Therefore genetic engineered pigs lacking both the GalT and the CMAH 
have been produced. (Vadori et Cozzi, 2015) 
 
2. Aims 
The present study aims to isolate and characterize glycosphingolipids from porcine 
pericardium in order to define glycosphingolipid antigens present in this tissue and compare 
it to glycosphingolipids of porcine heart valve cusps. Isolated glycosphingolipids are 
characterized by mass spectrometry and binding of carbohydrate recognizing ligand in solid-
phase binding assay. Furthermore, binding assays are done using serum from patients with 
BHV in order to define the antibody response of patients after prosthetic heart valve 
transplantation. 
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3. Methods and materials 
3.1. Materials 
Source of the samples 
Porcine pericardium was acquired from the local slaughterhouse. The pericardial tissue 
was surgically dissected and stored at -80 °C. 
Serum was collected before surgery and one and six months after the transplantation 
from 10 patients undergoing transplantation of bioprosthetic heart valves. The serum was 
stored at -80 °C. 
Other material 
For extraction and separation common laboratory glass and machines were used e.g. 
separation columns, flasks and tubes, water bath and tube gas evaporator and the analytical 
scales (d = 0.1 mg, Sartorius, Germany). 
Solvents: Dichloromethane (HPLC solvent; Fisons Scientific Equipment), chloroform 
(redistilled), methanol (redistilled) (VWR Chemicals), filtered water. 
Stationary phase: Silica gel 60 (0.040-0.063 mm; Merck KGaA), Iatrobeads (Iatron 
laboratories), DEAE cellulose (diethylaminoethyl cellulose) (Whatman)  
Dialysis tubes: (Spectra/Por Dialysis Membrane; Spectrum Laboratories, Inc.) 
TLC plates: HPTLC silica gel 60 (Glass plates 20×10 cm, Merck KGaA), HPTLC silica gel 60 
(Aluminium sheets 20×20 cm, Merck KGaA) 
Detection reagents for TLC:  
Resorcinol reagents: 
10 ml of resorcinol solution (1 g of the resorcinol (benzene-1,3-diol, Fluka AG, Germany) 
in 50 ml of H2O, 80 ml of HCl (Hydrochloric acid fuming 37% pro analysis, Merck, 
Germany), 0.25 ml of 0.1M CuSO4 (250 mg CuSO4 in 10 ml H2O). 
 
Anisaldehyde reagents: 
Anisaldehyde (4-methoxybenzaldehyde, Merck, Germany) in amount of 1 ml,  98 ml of 
acetic acid (Acetic acid (glacial) 100%, Emsure, Merck, Germany) and 2 ml of sulfuric acid 
95-97% (Sulfuric acid for analysis, Merck, Germany). 
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Carbohydrate binding assay ligands: 
 In the process of chromatogram binding assays following carbohydrate binding ligands 
were used: 
Ligand Clone/Designation Manufacturer/Reference Isotype Dilution 
Anti-Galα4Gal E coli 291-15 1 - - 






- Vector Laboratories Inc. - 1:100 
Aleuria aurantia lectin - Vector Laboratories - 1:100 
Anti-A MAb HE193 GeneTex/Abcam IgM 1:500 







Anti-GD1a  MAb GD1a-1-s DSHB IgM 1:100 
Anti-sialyl-lactotetra  
MAb * 
TR4/SL-50 2 IgM 1:200 
Anti-sialyl-
neolactotetra  MAb * 
LM1:1a 3 IgM 1:200 
 
* This antibody was a kind gift from Doctor Maria Blomqvist, Department of Clinical Chemistry and 
Transfusion Medicine 
Table 1: Antibodies and lectins used in Chromatogram Binding Assay (CBA) 
TLC References:  
Glycosphingolipids previously isolated and characterized by local research group. In 
particular total neutral GSLs from human erythrocytes blood group AB, acetylated 
sphingomyelin, calf brain gangliosides, GM3 from pig, sulfatide GSLs from pig, GD1a, GD3, 
GM1 and Gc-neolactohexaosyl glycosphingolipids. 
Human serum for binding assay:  
Frozen serum collected from each patient before, one and six month after BHV treatment 
were thawed and then diluted in ratio 1:9 with blocking solution. 
 




Human albumin 1% in PBS/BSA or Carbo-Free Blocking Solution (10× concentrate in 
H2O) (Vector laboratories, USA)  
Concentrated phosphate buffered saline (PBS):  
80 g NaCl, 2 g KCl, 11.5 g Na2HPO4.2H2O, KH2PO4, distilled water 1000 ml and 
subsequently diluted pro re nata by 10. 
Other: 
Plastic disposable Petri’s dishes, Pasteur pipettes and tubes (Sarstedt, Germany).  
Biomax MR Film XAR-5- x-ray films (Eastman Kodak Co.) (Carestream, U.S.A). 




Glycosphingolipids are a group of chemical compounds where physical-chemical and 
physiological properties vary a lot. In order to extract and purify glycosphingolipids, their 
differences in polarity and solubility in solvents has to be taken into account. Notable is that 
GSLs resist to alkaline degradation, whereas even weak acids may result in cleavage of 
glycosidic bond. 
Hence, various protocols for isolation of GSLs have been developed.  
The protocol used in our laboratory was developed by Karlsson (1987) and enables to 
obtain total acidic and total non-acidic glycosphingolipid fractions free of other lipid 
components. This procedure has been further modified to be applicable on small amounts 
of samples.  




Figure 7: Schematic overview of glycosphingolipid isolation, modified from (Barone, 2010) 
 
 Extraction of lipids 
Lyophilized porcine pericardium was extracted for 24 hours in a Soxhlet apparatus with 
mixture of chloroform and methanol (C:M) in 2:1 ratio and for another 24 hours with the 
mixture of the same solvents but in ratio 1:9 (v/v), the extraction was held in glass apparatus 
composed of flask, Soxhlet extractor, condenser and cooker. The liquid extracts were pooled 
and dried and the total lipid profiles were checked by thin layer chromatography. 




Figure 8: Soxhlet apparatus diagram, adapted from: (Berghe, 2003) 
Figure 9: TAG, FA and glycerol, modified from: (Jandacek, 1994) 
 Mild alkaline hydrolysis 
After extraction, mild alkaline hydrolysis was performed in order to cleave ester bonds, 
this facilitate the separation of glycerophospholipids from GSLs. 
  
Figure 10: Schematic formula of glycosphingolipid, adapted from: (Anonymous) 
Figure 11: Schematic formula of glycerophospholipid, adapted from: (SDSU, 2013) 
The glycosphingolipids stayed undamaged because of their structure, where 
carbohydrate residues are bound to ceramide core chain by etheric linkage (called O-
glycosidic), whereas glycerophospholipids and also the rest of triacylglycerides underwent 
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hydrolysis (or preferentially alkaline methanolysis) in this process. Therefore, 
glycophospholipids were deacylated (the removal of fatty acids esterified to glycerol), which 
resulted in fatty acid methyl-esters (the methyl group comes from methanol as the solvent) 
and polar glycerophosphoryl derivatives. The sphingomyelin, which always occurs in total 
lipid extracts, is not affected and stays unchanged. In this process possible O-acetylated 
glycolipids could be degraded. (Karlsson, 1987) 
To perform alkaline methanolysis, the solution of 0.2 M KOH in methanol were added 
to the mixture and incubated for 3 hours in darkness at room temperature.  
Figure 12: Schematic view of methanolysis; FA is fatty acid residue, R1 is the rest of 
glycerophospholipide or triacylglyceride 
 Dialysis 
The mixture was moved to a dialysis bag and C:M:W in ratio 8:4:3 was added in order to 
achieve a two phase system. Dialysis was then left for 3-4 days in a beaker with continuous 
income of tap water. The mechanism of dialysis is based on diffusion through the 
semipermeable membrane. Small molecules (like salts) and solvents are able to pass the 
membrane to the flowing liquid (tap water), but the macromolecules and in general 
everything larger than the pores cannot and stay.  
Although the individual molecular weight of glycosphingolipids is smaller than the pores 
in dialysis tubing, they are not lost during the dialysis. It is believed that this is caused by 
formation of micelles and the maintenance of the two-phase environment. (Henry, 1993) 
The dialysed extract was evaporated to dryness at 55 °C in water bath. 
 Silicic acid chromatography 
The separation is a foundation stone of isolation. There are many techniques based on 
divergent mechanism, but most common are those using silica gel and its modifications as a 
stationary phase. The silicic acid chromatography (SAC) is essential, simple and available 
technique for separation of compounds from samples. 
 




It is based on interaction of separated compounds with stationary and mobile phase. As 
stationary phase, silica gel is used. This is a hydrated form of silicic acid, which is an acidic 
adsorbent with many hydroxyl groups in the molecule. The interaction of molecules in the 
mobile phase with the silica gel (stationary phase) is mediated by van der Waals forces and 
hydrogen bonding. (Karlsson, 1987) 
Because of the relatively high polarity of the silica gel, polar substances will bind strongly 
to its surface and a more polar eluent will be required to elute it. Therefore, the first silicic 
acid chromatography enabled to separate the major part of less polar compounds like 
cholesterol and fatty acids methyl-esters from glycolipids and sphingomyelin by using a 
relatively non-polar solvent in the first step.  
 
Figure 13: TLC detected by anisaldehyde reagent showing difference before and after separation 
from fats. Fraction 1 are unseparated lipids, in fraction 2 are cholesterol and fatty acids, fraction 3 
are glycolipids and sphingomyelin, modified from (Barone, 2010). 
The separation was achieved by using the following solvents; dichloromethane, 1% 
methanol in chloroform, 2% methanol in chloroform, 75% methanol in chloroform and 
100% methanol. Three fractions were collected to the pre-weighted flasks according to close 
polarity of the solvents and monitored by TLC.  
 Acetylation and deacetylation 
Acetylation was performed in order to remove sphingomyelin from the rest of the 
sample. The chromatographic properties of sphingomyelin and glycolipids are similar. 
However, sphingomyelin has only one acetylation site, whereas glycosphingolipids, 
especially their glycosylated parts, have a lot of them. Therefore acetylation will change the 
glycolipids from the polar to the non-polar, while sphingomyelin stays in the polar group.  
As a consequence, the glycolipids can be separated from sphingomyelin. (Karlsson, 1987) 
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For acetylation a mixture of chloroform, pyridine and acetic anhydride in equal parts was 
used and incubated over night at a dark place. The reaction was stopped with the addition of 
methanol during cooling by ice.  
Acetylated GSLs were separated from sphingomyelin on a second silicic acid column. 
Thereafter the GSL-containing fraction was treated with methanol, toluene and 0.2M KOH 
in methanol in ratio 1:1:2 to revert the GSLs back to their original state. The process was 
followed by dialysis in order to remove part of reaction waste. 
Figure 14: Example of glycosphingolipid (Barone, 2010) 
Figure 15: Formula of sphingosine and sphingomyelin, adapted from: (Berg, et al., 2001) 
 Ion-Exchange Chromatography 
The method is based like silicic acid chromatography on separation of compounds 
according to chromatographic properties in the relationship to stationary and mobile phase. 
The difference between this kind of chromatography and SAC is that ion chromatography is 
used for a separation of ions and highly polar molecules. Mechanism of ion exchange 
chromatography is based on columbic (ionic) interactions between sample and stationary 
phase, which displays ionic functional groups of the opposite charge. (Weiss, 1995) 
 
 
~ 33 ~ 
 
 
Ion exchange chromatography separated acidic GSLs (sulfatides and gangliosides) from 
non-acidic GSLs. For this purpose, the solid phase DEAE was used. As the mobile phases 
were used first C:M (2:1) followed by pure methanol to elute less polar compounds including 
total neutral GSLs and then as the second mobile phase a 5% (w/v) solution of LiCl in 
methanol to elute the acidic compounds. Subsequent dialysis was performed for four days to 
remove salts.  
Further purifications, mainly by SAC, had to follow to get the product in sufficient purity 
for analysis. The fractions were further separated by chromatography on Iatrobeads 
columns. 
 Drying 
Drying is a method aiming to get rid of redundant volume of solvents after each process 
mentioned above. In addition, drying up all solvent present in the sample enable us to replace 
it with another one more suitable solvent for storing or sampling for TLC. 
For drying, water bath or tube heater were used under a stream of nitrogen (g) into flask 
or tube. 
 Thin layer chromatography  
Thin layer chromatography can be performed for getting a preliminary overview of GSLs 
in every step of the preparation. Like in the case of silicic acid column chromatography, the 
same principles are applied in TLC. Thus, separation of individual compounds depends on 
their polarity and size of the molecule. In the context of glycolipids, the length of the 
oligosaccharide chain with its rich hydroxylation and the ceramide play important roles. The 
position on TLC roughly indicates the number of carbohydrate residues in the glycolipid. 
Plates used in high performance thin layer chromatography are covered by uniform 
superfine silica gel and are manufactured on glass and aluminium plates.  
The preliminary identification was enabled by using suitable references, which was 
evolved in the same chamber by the same solvent system and on the same plate as the 
samples. Detection was then performed by using chemical staining with anisaldehyde or 
resorcinol reagent. Anisaldehyde colours all carbohydrates in different shades of green and 
resorcinol stains only those carbohydrates containing at least one molecule of any sialic acid 








On each line GSLs were applied and then developed in a chamber with a solvent 
composed of chloroform-methanol-water in 60:35:8 (v/v/v), dried, and then sprayed with 
one of the reagents. Then the plate was put into at 200 °C pre-heated oven for some time to 
facilitate the reaction with reagent.   
TLC is used for preliminary detection of GSLs. However, single band on the 
chromatogram may contain more glycosphingolipids with similar chromatographic 
properties. The identification is further complicated by the fact that GSLs are homogenous 
in their carbohydrate part, but may differ from each other in their sphingosine and fatty acid 
part. This results in multiple banding patterns of the same glycosphingolipid. Principles of 
TLC method enable to separate glycosphingolipids for further analytical usage. 
 Chromatogram Binding Assays 
This method has been originally invented by Magnani (1980) and has a great importance 
for characterization of GSLs.  
Aluminium sheets covered by silica gel are more suitable for chromatogram binding 
assays (CBA), due to their higher resistance to layer disruption during many washing steps 
than silica gel covered glass plates. 
Binding assay chromatograms with separated glycosphingolipids were dipped in 
diethylether/n-hexane (1:5 v/v) containing 0.5% (w/v) polyisobutylmethacrylate (Aldrich) 
for one minute. After drying, the plate was ready for binding assay of choice. This treatment 
prevents the destruction of silica gel due to repeated washing steps in the binding assays. The 
fixation of silica gel by this plastic is sufficient to make the silica gel layer compact, but not 
too much to obstruct sample-detection agent binding. 
Notable is the phenomenon of cross-reactivity in using antibodies, lectins and 
carbohydrate binding proteins. This and the fact that some carbohydrate epitope may be 
cryptic make binding assay characterization more difficult. In this context, it leads also to 
postulate, that the absence of binding does not prove the absence of certain epitope in the 
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CBA with lectins or specific monoclonal antibodies 
 The TLC was developed, dried and put into plastic solution for one minute and dried 
out properly, as mentioned above. 
The plate was then put into blocking solution (2% BSA in PBS) in order to prevent 
unspecific binding. The plate was incubated for 2 hours and after them was the blocking 
solution decanted and poured out. The plate was then incubated with 125I labelled lectins or 
with specific monoclonal antibodies (table 1). After 2 hours of incubation the plate was 
washed 6 times by PBS. In the case of specific antibodies 125I labelled secondary antibodies 
were applied, incubated and washed as above. Dried chromatograms were autoradiographed 
for 6-48 hours. 
 
 
Figure 16: Example of TLC plate detected by autoradiography (left) and by chemical reagent (right) 
CBA with the sera of the patients 
The main difference between this and previously mentioned kind of binding assay is 
application of real patient serum containing antibodies instead of specific reagent. The aim 
is to find out whether the tested serum sample contains any antibodies directed against 
already characterized carbohydrates or their mixtures. 
In this protocol the TLC plates with tested GSLs were prepared, developed and treated in 
plastic as before. Then 1% albumin or a carbohydrate free blocking solution as a blocking 
solution was poured on the TLC plate to prevent unspecific binding in further process. The 
incubation of the blocking solution lasted 2 hours and then it was poured out.  
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In the next step, the patient serum diluted in ratio 1:10 by the blocking solution was 
carefully poured on the TLC plate and left to incubate again for 2 hours. Afterwards the TLC 
plate was washed 6 times with PBS.  The secondary anti-human Ig antibodies diluted in an 
appropriate blocking solution in ratio 1:100 (v/v) were poured on the washed TLC plates. 
After 2 hours of incubation, 6 times washings followed to get rid of unbound secondary 
antibodies.  
The secondary antibodies marked by radioactive isotope of iodine were directed against 
primary human antibodies. This visualisation step enabled us to detect them by 
autoradiography. 
Dry TLCs were fixed into metal cassette and the special film was put on them in the dark 
room. After sufficient time the film was developed and evaluated. 
 
Figure 17: Radioactive iodine marked secondary antibodies, modified from (Barone, 2014b) 
 Mass spectrometry 
Mass spectrometry (MS) is a key analytical technique for characterization of 
glycosphingolipids. The MS is based on ionization of the molecules in the sample, by both 
adding and removing charge and subsequent separation of them according to their m/z ratio 
in order to detect them by a detector.   
In the context of glycolipid MS provides valuable information about the number of 
carbohydrate residues, carbohydrate sequence, branching points and type of sugar residue 
(hexose, pentose, deoxyhexose, sialic acid, hexosamine). (Karlsson, et al., 2010) 
 It should be noted that mass spectrometry is not “one size fits all” kind of method, thus 
different compounds may need different methods for ionization and detection. Therefore, 
more modifications for analysis of glycosphingolipids have been developed. 
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A previously used method called electron ionization (EI) was used for this analysis of 
GSLs. To briefly explain, this method used evaporation of a sample by heat on high voltage 
electrode. This caused a lot of problems due to damage of unstable GSLs; and this is why 
another solution came with introducing of soft ionization techniques such as Electrospray 
Ionization (ESI). 
ESI works on the mechanism based on the production of small droplets of liquid sample 
from metal capillary at voltage 3.5 kV and their nebulization. This fine spray from liquid 
sample is rapidly evaporated by heat and dry nitrogen. The ionized analytes then continue 
into highly evacuated through a series of small orifices and focusing voltages to detector. 
(Pitt, 2009) 
The ESI-MS which is used for characterization of glycosphingolipids in this study does 
not require high heat in the process of ionization. However, it has a few disadvantages like 
low sensitivity or no fragment ions creation. This was solved by introduction of nano-ESI 
which increased sensitivity and mass tandem (MS/MS or MS2), which enabled fragmentation 
of ions. (Karlsson, et al., 2010) 
In our measurements LC-ESI/MS was used: 
The glycosphingolipids (dissolved in methanol/acetonitrile 75:25, by volume) were 
separated on a 200 x 0.150 mm column, packed in-house with 5 mM polyamine II particles 
(YMC Europe GMBH, Dinslaken, Germany), and eluted with a water gradient (A: 100% 
acetonitrile; B: 10 mM ammonium bicarbonate). Samples were analysed on an LTQ linear 
quadrupole ion trap mass spectrometer (Thermo Electron) by LC-ESI/MS at -3.5 kV. Full-
scan (m/z 500-1800, 2 microscans, maximum 100 ms, target value of 30 000) was performed, 
followed by data dependent MS2 scans (2 microscans, maximum 100 ms, target value of 10 
000) with normalized collision energy of 35%, an isolation window of 2.5 units, an activation 
q = 0.25, and an activation time of 30 ms. 
Manual assignment of glycosphingolipid sequences was done with the assistance of the 
Glycoworkbench tool (Version 2.1), and by comparison of retention times and MS2 spectra 
of reference glycosphingolipids. 
 
 




4.1. Isolation of NeuGc-containing GSL from goat Erythrocytes 
780 mg of total acidic glycosphingolipid fraction from goat erythrocytes was separated 
first by 2%, 10%, 75% and 100% methanol in chloroform and then repeatedly by C:M:W 
(60:35:8) on silicic acid (Iatrobeads) columns. Finally, 17 fractions were obtained and 
characterized by LC-ESI/MS. 
4.2. MS characterization of NeuGc-containing GSL from goat 
erythrocytes 
In one of the fractions obtained the NeuGc-GT1b ganglioside was characterized (result 
fig. 1). This sample was later used as reference in the binding assays. (result fig. 8) 





Result figure 1: LC-ESI/MS of an acidic glycosphingolipid fraction isolated from goat 
erythrocytes. 
A. Base peak chromatogram. 
B. MS2 spectrum of the [M-2H+]2- ion at m/z 975. 
C. MS3 spectrum of the ion at m/z 1335. 
D. Interpretation formula showing the deduced glycosphingolipid sequence. 
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4.3. Isolation GSLs from porcine pericardium 
108 gram wet weight (72 gram dry weight) porcine pericardium was extracted by C:M 
(2:1) and C:M (1:9) for 24 hours per solvent in Soxhlet apparatus. After drying it was treated 
with 0.2M solution of KOH and then dialyzed for 4 days. The 62 gram thereby obtained were 
repeatedly separated on silicic acid separation column by dichloromethane, 1%, 2% MiC and 
by 75%, 100% MiC. All fractions containing GSLs were pooled.  
1.8 gram of sample was acetylated by mixture of CHCl3, pyridine and acetic anhydride 
and left over night in dark place. Acetylation was stopped by addition 50 ml MeOH during 
cooling by ice. Next separation on silica-gel (DiChl; 5%; 7.5%; 75% and 100% MiC) was 
performed to get rid of acetylated sphingomyelin. Fraction of interest was deacetylated by 
mixture of MeOH, toluene and 0.2M KOH in MeOH, then dialyzed for 4 days and dried to 
dryness on the water bath. Ion exchange chromatography with C:M (2:1) and 5% LiCl in 
MeOH on a DEAE column was performed to divide roughly fractions containing acidic and 
non-acidic glycosphingolipids. 
The non-acidic sample underwent a few further silicic acid chromatographies resulting 
in 43.0 mg of total non-acidic glycosphingolipid fraction. 
The acidic GSL sample was first dialyzed for 4 days and then repeatedly separated on 
silica gel columns. After pooling three fractions were collected: ganglioside fraction (total 
amount 5.2 mg), sulfatide fraction (total amount 1.0 mg) and sulfatide/ganglioside mixture 
(total amount 0.9 mg). 
Each separation step was checked by HPTLC. 
4.4. Characterization of GSLs from porcine pericardium 
The isolated samples were, as described above, analysed on an LTQ linear quadrupole 
ion trap mass spectrometer (Thermo Electron) by LC-ESI/MS at -3.5 kV. Then manual 
assignment of glycosphingolipid sequences was done with the Glycoworkbench tool 
(Version 2.1), and by comparison of retention times and MS2 spectra of reference 
glycosphingolipids. 
The specific ligand carbohydrate binding assays were performed separately with acidic 
and with non-acidic glycosphingolipids.  
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4.5. LC-ESI/MS characterization of non-acidic GSLs 
 
 















Result figure 2: LC-ESI/MS of the oligosaccharides obtained by digestion of the non-acidic 
glycosphingolipid fraction of porcine pericardium (Tab. 1) with Rhodococcus 











































Table 2: Summary of non-acidic glycosphingolipids characterized in porcine pericardium 
by LC-ESI/MS. 
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Result figure 4: Characterization of the non-acidic glycosphingolipids of porcine 
pericardium by antibody and lectin binding. 
Thin-layer chromatogram after detection with anisaldehyde (A) and autoradiograms 
obtained by binding of P-fimbriated E. coli strain 291-15 (B), E. cristagalli lectin (C), G. 
simplicifolia IB4 lectin (D), monoclonal antibodies directed against the blood group H type 
1 determinant (E), and monoclonal antibodies directed against the blood group A 
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Result figure 4: LC-ESI/MS of the gangliosides of porcine pericardium. 
 
Base peak chromatogram from LC-ESI/MS of the acid glycosphingolipid fraction Pa-III 
from porcine pericardium. The structures of identified gangliosides, and the abbreviations 













Table 3: Summary of gangliosides characterized in porcine pericardium by LC-ESI/MS. 
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Result figure 6: Characterization of the acidic glycosphingolipid fraction of porcine 
pericardium by antibody and toxin binding. 
Thin-layer chromatogram after detection with anisaldehyde (A), and autoradiograms 
obtained by binding of monoclonal antibodies directed against the NeuAcα3-neolacto 
epitope (B), monoclonal antibodies directed against the GD1a ganglioside (C), and cholera 














4.9. Carbohydrate binding assay with human serum  
In total number of 60 binding assays with the serum of patients before, one month and 














Result figure 7: Increased binding of human serum to Galα3-terminated glycosphingolipids 
after bioprosthetic heart valve transplantation. 
Thin-layer chromatogram after detection with anisaldehyde (A), and autoradiograms 
obtained by binding of human serum taken before surgery (B), one month after surgery (C), 































Result figure 8: Increased binding of human serum to NeuGc-GM3 after bioprosthetic heart 
valve transplantation 
Thin-layer chromatogram after detection with anisaldehyde (A), and resorcinol (B), and 
autoradiograms obtained by binding of human serum taken before surgery (C), one month 
















































~ 50 ~ 
 
 
5. Discussion  
This study was designed to contribute by its findings to solve the questions - why do 
transplanted bioprosthetic heart valves (BHV) deteriorate with time and which mechanisms 
are involved in this process?  
In this study glycosphingolipids from different animal tissues have been isolated, 
characterized and assessed as potential targets of human immune response after BHV 
transplantation. 
5.1. Summary of GSL findings in porcine pericardium 
Isolation 
Total acidic and total non-acidic glycosphingolipids from porcine pericardium have been 
isolated by the preparation method derived by Karlsson (1987).  
Chemical and physical-chemical properties were used in order to extract, purify and 
separate them into groups suitable for analysis. In particular, solubility was used in extraction 
of raw material by C:M (2:1) and C:M (1:9), polarity in all silicic and ion-exchange 
chromatographies and chemical reactivity in removal of sphingomyelin. 
All of final collected fractions, particularly: total neutral glycosphingolipid fraction (total 
amount 43.0 mg), ganglioside fraction (total amount 5.2 mg), sulfatide fraction (total 
amount 1.0 mg) and sulfatide/ganglioside mixture (total amount 0.9 mg). 
Characterisation 
LC-ESI/MS analysis was facilitated by foregoing digestion of the non-acid GSLs by 
Rhodococcus endoglycoceramidase II, which breaks linkage between ceramide and 
oligosaccharide part of the GSL (divides glycone and aglycone). Then manual assignment of 
GSL sequences was done with the Glycoworkbench tool (Version 2.1), and by comparison of 
retention times and MS2 spectra of reference glycosphingolipids. Eight non-acidic GSLs and 
seven acidic GSLs were characterized by this method (tables 2 and 3). 
CBA characterisation of the non-acidic GSLs was performed by monoclonal antibodies 
(MAb) and by lectins. Notable is that in other lanes were situated GSLs used as references, 
which have been already isolated and characterized by LC-ESI/MS. 
Reactivity of acidic GSL from porcine pericardium with MAb directed against NeuAcα3-
neolacto epitope, MAb directed against GD1a ganglioside and cholera toxin B-subunits 
(Ludwig, et al., 1985) is shown in the result figure 6. These results revealed presence of GD1a, 
NeuAcα-neolacto and NeuAc-GM3 in the sample, where the GD1a was the major one. 
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The non-acidic GSL from porcine pericardium were characterized by specific antibodies 
and by lectins as it is shown in the result figure 4. 
The binding to P-fimbriated E. coli confirmed the presence of globotetraosylceramide in 
the GSL sample from porcine pericardium. This ligand has a specific reaction with 
Gal(α1,4)Gal antigens. (Roberts, et al., 1994) 
In the same manner the binding of the Galα3-recognizing G. simplicifoila IB4 lectin 
(Goldstein, 1983) confirmed the presence of Galα3-neolactopenta- and Galα3-
neolactoheptaosylceramide. 
The other tested ligands showed no distinct binding to the non-acid GSLs of porcine 
pericardium. 
Context of our findings 
Although BHV are routinely used, clinical BHV treatment still suffers from 
complications such as hyperacute rejection or fast deterioration with time and subsequent 
loss of function. It has been shown that the major part of negative immunity response against 
xenograft is targeted to the Galα3 antigen. However other antigens such as NeuGc also have 
important roles. (Vadori et Cozzi, 2015). 
One goal of this study is isolation and characterization of glycosphingolipids, as potential 
antigens of porcine pericardium, which is one of the materials in use for BHV manufacture. 
Studies concerning about isolation and characterization have been already performed 
with porcine valves (Lee, et al., 2015) and porcine valve cusps. (Barone, et al., 2014a) 
Comparison with them gives us image about diversity among these tissues in GSL 
composition i.e. absence of NeuGc in porcine cusps (Barone, et al., 2014a). These differences 
might be those which involve intensity of immune response against material from which 
xenografts are manufactured. 
Our results correlates with findings of other studies (Lee, et al., 2015) and confirms also 
presence of Galα3 and NeuGc antigens in some porcine tissues, particularly in porcine 
pericardium. The first two are not biosynthesized in human tissues and therefore they are 








5.2. Isolation of GSL from goat erythrocytes 
Findings 
In order to identify as many naturally occurring GSLs as possible, one part of my work is 
concerned about isolation of GSL from goat erythrocytes. My work represents only the final 
parts of isolation and analysis. 
From the goat erythrocytes was isolated new NeuGc-containing ganglioside - NeuGc-
GT1b which was characterized by LC-ESI/MS as described in figure 1. However, there are 
over 350 already described carbohydrate chains in GSLs (Merril, 2011), the characterization 
of any new might be in the future useful for studies in xenotransplantation field as well as in 
studies in other fields i.e. transdermal drug delivery systems or cell membrane concerning 
studies. 
5.3. Reactivity with human serum 
To sum it up, the most important antigen structures causing complications in 
xenotransplantation are: 
• Galα3 – Antigen missing in all humans, apes and Old World monkeys due to 
evolutionary loss of enzyme α-1,3-galactosyltransferase and represented by terminal α-
galactose of carbohydrate sequence in many tissues. It is the major barrier in 
xenotransplantation and several approaches to avoid complications caused by it have 
been invented. 
• NeuGc – Antigen is not synthesized in humans due to lacking of enzyme CMAH. It is 
considered as the main target of immune response against xenografts from Galα3 
antigen lacking donors. 
In order to investigate which antigens are targets of immune response mediated by 
antibodies, 60 binding assays with the patient serum have been performed. The sera of the 
patients have been collected before surgery, one month and six months after transplantation 
of heart valve made from porcine pericardium and then was tested with different GSLs and 
their mixtures to find out if there are any antibodies targeting them. This would help to 
clarify not only which glycosphingolipids are the targets, but also change of targets and 
intensity in the time. 
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Testing of non-acidic GSL 
30 binding assays with non-acid GSLs and with patients’ serum have been done using 
described protocol and detected by autoradiography. Autoradiography on special films was 
detecting radioactive rays from 125I-marked antibodies used for detection human antibodies 
against GSL in the sample. 
The results are mostly negative but occasionally an increased binding to antigens with 
terminal Galα3 is seen. In the cases where this was revealed, increased binding occurred in 
the samples from bovine pericardium and from rabbit erythrocytes. 
Progress in the time has not been clearly observable. However, in a few samples intensity 
of observed reactivity increased with the time. 
Testing of acidic GSL 
The GSL from porcine pericardium and reference NeuAc-GM3, NeuGc-GM3 and 
NeuGc-GD1b gangliosides have been tested with patient serum. The binding was mostly 
negative, occasionally increased, especially in the samples from porcine pericardium and 
NeuGc-GM3 ganglioside.  
No conclusion in time-relation was found. However, the intensity of strips on the plates 
mostly decreased with the time. 
Context of our findings 
Our data collaborates with the previous theory about induced antibody response against 
Galα3 antigen after xenotransplantation of graft from porcine tissues. (Mangold, et al., 2009) 
Also, it is extending findings about porcine BHV (Barone, et al., 2014a) due to tests of 
occurring GSL with real patients’ serum. Notable is that in this study porcine cusps were 
isolated and those in opposite to porcine pericardium do not contain NeuGc antigen. 
The results of binding assay might be changed by the change of blocking solution during 
the study. The change from 1% human albumin in PBS solution was switched to carbo-free 
blocking solution. The replacement of blocking solution led to better observability of strips 
on plates. Carbo-free in the name of new blocking solution means, that it does not contain 
any carbohydrates potentially leading to unspecific blocking of antibody binding.  
It has been already shown that there is a relationship between BHV deterioration 
especially by process of calcification (Human, et al., 2001) and immune response. This is why 
the knowledge of reactivity of antigens with antibodies present in human body before and 
after xenotransplantation is important.  
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Once the targets of immunity and mechanisms of deterioration are known, several 
methods could be invented to avoid complications caused by them i.e. production GalT-KO 
pigs (McGregor, et al., 2013), anti-calcification procedure (Choi, et al., 2016), antigen 
removing protocols such as (Nam, et al., 2012) or glutaraldehyde treatment (Siddiqui, et al., 
2009). The suppression of human immune reactivity against xenograft like thymus 
transplantation or mixed chimerism due to bone marrow transplantation is also a possible 
way to prevent damage of the graft. (Griesemer, et al., 2014) 
5.4. Future research perspective 
The study helps to increase the knowledge about glycosphingolipids as possible targets 
for immune response against graft. In the future, this knowledge would help to clarify 
mechanisms of BHV deterioration caused by calcification and other mechanisms and in the 
final impact would help to increase final outcome from xenotransplantation.  
As subsequent logical steps based on my results, I would recommend for future 
researchers to explore next potential carbohydrate and non-carbohydrate antigens because 
the greater knowledge about them we have, the earlier ideas for avoiding complications 
connected with them would be thought of.  
Based on our results, the usage of pericardial tissue from blood group 0 pigs with 
knockout of GalT + CMAH for BHV would be one of these complication avoiding ideas. 
Also screening of GSLs in next animal tissues would be recommended in order to get the 
most antigenic suitable source of material for manufacturing of BHV. 
Last, but not less important is also to properly investigate the mechanism and antibody 
contribution to the valve calcification, which seems to be essential process in BHV early 


















The current study contributes to the knowledge about glycosphingolipids as antigens in 
bioprosthetic heart valves.  
1. From porcine pericardium 8 non-acidic and 7 acidic GSL have been isolated and 
characterized by LC/MS-ESI and CBA. Notable is the presence of the Galα3 and the 
NeuGc antigens in the tissue. 
2. All total neutral GSL from goat erythrocytes have been isolated and characterized by 
LC/MS-ESI. In this sample new GSL containing NeuGc (NeuGc-GT1) has been 
characterized. 
3. Finally, the reactivity of GSLs isolated from porcine pericardium, goat erythrocytes and 
from other samples have been tested via series of binding assays with the serum of the 
patients, who patients who underwent treatment with BHV. Results were mostly 
negative. However in a few samples increased reactivity with Galα3 and NeuGc antigens 
was revealed. 
The knowledge about composition of GSL in various tissues and about their reactivity 
with human immunity helps to clarify why BHV treatment suffers from early deterioration 
of BHV due to calcification and other mechanisms and also helps to prevent complications 
connected with xenotransplantation treatment such as hyperacute reaction.  
Also it creates more solid background for development of the methods used for getting 
rid of these antigens from the xenograft or antibodies against them from the recipient’s body. 
These methods especially development GalT-KO and CMAH-KO (Galα3 and NeuGc free) 
pigs combined with transgenetic modulation of complement and haemostasis and 
exploration for next potential antigens should be further researched.  
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